Drug Screening Core
The Drug Screening Core will build into a high-end biomedical R&D platform aims to explore and deliver innovative treatment measures for major diseases (e.g. cancer and neurodegenerative diseases).
-
This core will comprise two subsidiary platforms:
-
Biomedical discovery subsidiary platform for large biomolecules, such as peptides, proteins, and monoclonal antibodies
-
High-throughput drug screening subsidiary platform
